The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical research policy for oral mucositis associated with cancer treatment (J-SUPPORT).
 
Tomoya Yokota
Honoraria - Abbott; Bristol-Myers Squibb; Chugai Pharma; Eisai; Merck; MSD; Ono Pharmaceutical
Consulting or Advisory Role - Astellas Pharma; Japan Agency for Medical Research and Development; Merck; MSD; Pharmaceuticals and Medical Devices Agency; Rakuten Medical
Research Funding - Ascent Pharmahealth (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Chugai/Roche (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Japan Agency for Medical Research and Development; Lilly Japan (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Syneos Health (Inst)
 
Takao Ueno
Honoraria - Maruho
 
Yoshihiko Soga
Honoraria - Maruishi Pharma; Otsuka
Research Funding - Maruishi Pharma
 
Hiroto Ishiki
Speakers' Bureau - Daiichi Sankyo/Lilly; EA Pharma; Hisamitsu Pharmaceutical; Mundipharma; Pfizer; Shionogi
 
Yasuhito Uezono
No Relationships to Disclose
 
Takehiko Mori
Honoraria - Abbvie; Asahi Kasei; Astellas Pharma; AstraZeneca; Chugai Pharma; CSL Behring; Daiichi Sankyo Pharmaceutical; Eisai; Janssen; Japan Blood Products Organization; Kyowa Kirin; Meiji Seika Kaisha; Mochida Pharmaceutical Co. Ltd.; MSD; Novartis; Ono Pharmaceutical; Otsuka; Pfizer; Sanofi; Sumitomo Dainippon Pharma; SymBio Pharmaceuticals; Takeda
Research Funding - Abbvie; Asahi Kasei; Bristol Myers Squibb Foundation; Chugai Pharma; CSL Behring; Daiichi Sankyo Pharmaceutical; Eisai; Japan Blood Products Organization; JCR Pharmaceuticals; Kyowa Kirin; Mochida Pharmaceutical Co. Ltd.; Ono Pharmaceutical; Otsuka; Shionogi; Sumitomo Dainippon Pharma; Taiho Pharmaceutical; Takeda; Teijin Ltd
 
Sadamoto Zenda
Honoraria - Bristol-Myers Squibb Japan; Maruho; Merck; Ono Yakuhin